English
Segment disclosures
Company overviewACHARI VENTURES HOLDINGS CORP. I
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
VASOCORPORATION · Commission · Professional Sales Service Segments
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:CommissionMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ProfessionalSalesServiceSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 8837000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 26401000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 9237000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 24424000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Commissions · Professional Sales Service Segment
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:CommissionsMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ProfessionalSalesServiceSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 37344000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 29441000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Commissions · Total
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:CommissionsMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:TotalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 37344000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 29441000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Medical Equipment Sale · Equipment Segments
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:MedicalEquipmentSaleMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:EquipmentSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 714000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2036000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 728000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1696000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Medical Equipment Sales · Equipment Segment
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:MedicalEquipmentSalesMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:EquipmentSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 2450000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3093000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Medical Equipment Sales · Total
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:MedicalEquipmentSalesMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:TotalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 2450000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3093000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Medical Equipment Service · Equipment Segment
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:MedicalEquipmentServiceMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:EquipmentSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 123000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 129000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Medical Equipment Service · Total
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:MedicalEquipmentServiceMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:TotalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 123000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 129000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Medical Equipment Services · Equipment Segments
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:MedicalEquipmentServicesMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:EquipmentSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 31000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 94000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 32000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 93000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Network Services · IT Segment
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:NetworkServicesMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ITSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 35833000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 37861000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Network Services · Total
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:NetworkServicesMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:TotalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 35833000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 37861000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Networks Service · IT Segment
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:NetworksServiceMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ITSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 8849000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 26833000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 8787000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 26705000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Revenue Recognized At A Point In Time · Equipment Segment
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:RevenueRecognizedAtAPointInTimeMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:EquipmentSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 2248000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3023000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Revenue Recognized At A Point In Time · IT Segment
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:RevenueRecognizedAtAPointInTimeMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ITSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 3011000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 4744000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Revenue Recognized At A Point In Time · Professional Sales Service Segment
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:RevenueRecognizedAtAPointInTimeMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ProfessionalSalesServiceSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 37344000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 29441000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Revenue Recognized At A Point In Time · Total
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:RevenueRecognizedAtAPointInTimeMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:TotalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 42603000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 37208000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Revenue Recognized Over Time · Equipment Segment
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:RevenueRecognizedOverTimeMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:EquipmentSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 325000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 199000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Revenue Recognized Over Time · IT Segment
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:RevenueRecognizedOverTimeMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ITSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 37089000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 38172000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Revenue Recognized Over Time · Total
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:RevenueRecognizedOverTimeMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:TotalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 37414000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 38371000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Software Sale And Support · IT Segment
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:SoftwareSaleAndSupportMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ITSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 1018000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 3743000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 1049000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 3153000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Software Sales And Support · IT Segment
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:SoftwareSalesAndSupportMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ITSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 4267000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 5055000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Software Sales And Support · Total
Consolidated Entities · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;srt:ProductOrServiceAxis=avhiu:SoftwareSalesAndSupportMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:TotalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 4267000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 5055000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Equipment Segment
Consolidated Entities · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:EquipmentSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 2573000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 3222000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Equipment Segments
Consolidated Entities · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:EquipmentSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 745000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2130000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 760000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1789000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Equipment Segments · Revenue Recognized At A Point In Time
Consolidated Entities · Statement Business Segments · Timing Of Transfer Of Good Or Service
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:EquipmentSegmentsMember;us-gaap:TimingOfTransferOfGoodOrServiceAxis=avhiu:RevenueRecognizedAtAPointInTimeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 524000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1668000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 676000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1557000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Equipment Segments · Revenue Recognized Over Time
Consolidated Entities · Statement Business Segments · Timing Of Transfer Of Good Or Service
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:EquipmentSegmentsMember;us-gaap:TimingOfTransferOfGoodOrServiceAxis=avhiu:RevenueRecognizedOverTimeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 221000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 462000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 84000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 232000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Information Technology
Consolidated Entities · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:InformationTechnologyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 9867000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 30576000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 40100000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 9836000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 29858000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 42916000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · IT Segment
Consolidated Entities · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ITSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 9867000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 30576000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 40100000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 9836000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 29858000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 42916000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · IT Segment · Revenue Recognized At A Point In Time
Consolidated Entities · Statement Business Segments · Timing Of Transfer Of Good Or Service
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ITSegmentMember;us-gaap:TimingOfTransferOfGoodOrServiceAxis=avhiu:RevenueRecognizedAtAPointInTimeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 565000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2396000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 616000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2328000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · IT Segment · Revenue Recognized Over Time
Consolidated Entities · Statement Business Segments · Timing Of Transfer Of Good Or Service
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ITSegmentMember;us-gaap:TimingOfTransferOfGoodOrServiceAxis=avhiu:RevenueRecognizedOverTimeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 9302000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 28180000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 9220000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 27530000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Professional Sales Service
Consolidated Entities · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ProfessionalSalesServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 8837000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 26401000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 37344000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 9237000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 24424000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 29441000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Professional Sales Service Segment
Consolidated Entities · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ProfessionalSalesServiceSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 37344000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 29441000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Professional Sales Service Segments
Consolidated Entities · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ProfessionalSalesServiceSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 8837000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 26401000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 9237000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 24424000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Professional Sales Service Segments · Revenue Recognized At A Point In Time
Consolidated Entities · Statement Business Segments · Timing Of Transfer Of Good Or Service
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:ProfessionalSalesServiceSegmentsMember;us-gaap:TimingOfTransferOfGoodOrServiceAxis=avhiu:RevenueRecognizedAtAPointInTimeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 8837000 | USD | 20240108 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 26401000 | USD | 20240108 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 9237000 | USD | 20240108 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 24424000 | USD | 20240108 | Open filing evidence |
VASOCORPORATION · Total
Consolidated Entities · Statement Business Segments
Source dimensions
srt:ConsolidatedEntitiesAxis=avhiu:VASOCORPORATIONMember;us-gaap:StatementBusinessSegmentsAxis=avhiu:TotalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 80017000 | USD | 20240108 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 75579000 | USD | 20240108 | Open filing evidence |